Core Points - Rosen Law Firm is reminding investors of Perrigo Company plc about the January 16, 2026 deadline to join a securities class action lawsuit related to the company's performance during the class period from February 27, 2023, to November 4, 2025 [2][3] Group 1: Class Action Details - Investors who purchased Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4] - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from underinvestment and significant manufacturing deficiencies [6] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [5] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [5]

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][3]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025, inclusive [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including issues related to underinvestment, necessary capital expenditures, and manufacturing deficiencies [6]. - As a result of these misstatements, Perrigo's financial results were overstated, leading to investor damages when the true information became public [6].

Core Points - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, lead plaintiff deadline for a class action lawsuit [1][2] Group 1: Class Action Details - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [2] - Investors can join the class action by visiting the provided link or contacting the law firm directly [5] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in recovering funds [3] Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment [4] - It is claimed that Perrigo needed to make substantial capital and operational expenditures beyond its stated cost estimates to address issues in the infant formula business [4] - The lawsuit asserts that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results [4]

NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Perrigo Company plc ("Perrigo Company plc" or the "Company") (NYSE: PRGO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perrigo Company plc investors who were adversely affected by alleged securities fraud between February 27, 2023 and November 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1 ...

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company misled investors regarding its financial health and the state of its acquired infant formula business [1][3]. Group 1: Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchased between February 27, 2023, and November 4, 2025 [1]. - Investors have until January 16, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Perrigo and its executives made false statements and failed to disclose critical issues regarding the infant formula business acquired from Nestlé [3]. Group 2: Allegations Against Perrigo - The complaint states that the acquired infant formula business suffered from significant underinvestment, requiring substantial capital expenditures beyond initial estimates [3]. - Manufacturing deficiencies were reported in the facility, leading to overstated financial results, including earnings and cash flow [3]. - On February 27, 2024, Perrigo disclosed additional costs of $35 million to $45 million for remediation, resulting in a 50% decline in earnings per share compared to the previous year [4]. Group 3: Financial Impact - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, attributed to lower shipments as the company addressed remediation plans [5]. - The gross margin fell to 36.5%, a decline of 90 basis points, with a significant impact from the infant formula business [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million, or 6.9%, with a reported gross margin of 34.4%, down 260 basis points [6]. Group 4: Strategic Review and Outlook - On November 5, 2025, Perrigo announced a strategic review of its infant formula business and reassessed its previously announced investment of $240 million [7]. - The company slashed its fiscal year 2025 outlook, projecting net sales growth of -2.5% to -3%, down from an expected 0% to 3% [7]. - Expected adjusted diluted earnings per share were revised to a range of $2.70 to $2.80, significantly lower than the previous range of $2.90 to $3.10 [7].

Core Insights - The Magnum Ice Cream Company (TMICC) aims to lead the frozen snacking market with a focus on innovation and customer service, backed by a clear growth strategy [2][5] - TMICC has a medium-term organic sales growth target of 3-5% annually, which is above Unilever's historical average of 3% [4][19] - TMICC is now the world's largest standalone ice-cream manufacturer, commanding a 21% global market share, nearly double that of its nearest competitor [5][27] Financial Performance - TMICC's revenue for the last year was reported at €7.95 billion, an increase from €7.62 billion the previous year, with adjusted operating profit rising to €964 million from €854 million [24] - The adjusted EBITDA margin improved to 16.9% from 15.9%, with adjusted EBITDA increasing to €1.34 billion from €1.21 billion [24] - Organic sales growth in 2024 was 2%, with the same rate maintained in the first half of 2025 [23] Market Strategy - TMICC plans to increase advertising and promotional spending to 13% of group revenues by 2026, up from 12.4% last year [7] - The company is focusing on e-commerce as a significant growth channel, complementing traditional retail and out-of-home sales, which account for about 40% of total turnover [17] - TMICC has implemented a €500 million productivity plan aimed at enhancing supply chain efficiency and tech-enabled productivity in manufacturing [20] Corporate Structure and Governance - TMICC is led by CEO Peter ter Kulve and CFO Abhijit Bhattacharya, with a board comprising experienced executives from various industries [22] - The company is addressing governance issues related to the Ben & Jerry's Foundation, which has been a point of contention following the demerger from Unilever [8][9] - TMICC's management is focused on capital allocation and innovation tailored to the ice-cream category, free from the broader priorities of Unilever [16][27] Future Outlook - Analysts suggest that TMICC's separation from Unilever will allow for improved performance and focus on higher-margin growth areas [27][28] - Unilever is reportedly considering divesting other food brands to concentrate on beauty and wellness sectors, indicating a strategic shift in its business model [25][26]

Core Viewpoint - The Vanguard International High Dividend Yield Index Fund ETF (VYMI) significantly outperformed the S&P 500 in 2025, returning 29.6% compared to the S&P 500's 15.6% gain, raising questions about its ability to replicate this performance in 2026 [2][4]. Performance Drivers - The fund tracks the FTSE All-World ex-US High Dividend Yield Index, holding over 1,500 dividend-paying stocks from developed and emerging markets, which benefited from favorable macroeconomic conditions in 2025 [4]. - European stocks surged due to Germany's announcement of approximately $1.3 trillion in infrastructure and defense spending over the next decade, positively impacting the fund's financial services allocation [6]. - The weakening U.S. dollar in 2025 provided an additional boost to returns for U.S. investors, marking the dollar's worst first-half performance since 1973 [7]. Fund Characteristics - The fund has a low expense ratio of 0.17% and a dividend yield near 4%, which is more than double that of the S&P 500 [8]. - It trades at a price-to-earnings ratio of around 13, indicating a notable discount compared to U.S. large-cap growth stocks [8]. - The market-cap weighting of the portfolio favors larger, stable dividend payers, reducing the risk of yield traps [9]. Future Outlook - Potential catalysts for continued performance include NATO members' commitment to increase defense spending and the possibility of narrowing price-to-earnings multiples between international and U.S. stocks [10][11]. - The fund's significant allocation to financial services (42%) poses concentration risk, particularly if bank earnings decline or loan growth stagnates [12]. Diversification Benefits - Holding international exposure can reduce portfolio volatility over time, as U.S. and foreign business cycles do not always align [13]. - The Vanguard International High Dividend Yield ETF remains an attractive option for investors seeking income and diversification, regardless of whether 2026 will replicate 2025's success [14].

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased Perrigo securities between February 27, 2023, and November 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment [5]. - It is claimed that Perrigo needed to make substantial capital and operational expenditures beyond its stated cost estimates to address issues in the infant formula business [5]. - The lawsuit also points out significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [5].

Core Points - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Company Details - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, including significant underinvestment in maintenance and the need for substantial capital expenditures [4] - The lawsuit claims that Perrigo's financial results, including earnings and cash flow, were overstated due to these issues, leading to misleading positive statements about the company's business and prospects [4] Legal Process - To join the class action, investors can submit a form or contact the law firm directly, with a lead plaintiff needing to move the court by January 16, 2026 [2][5] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Summary by Sections Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc, and it covers securities purchases made between February 27, 2023, and November 4, 2025, with a deadline for lead plaintiff applications set for January 16, 2026 [1][2]. Acquisition and Allegations - Perrigo acquired Nestlé's Gateway infant formula plant for $170 million in November 2022, along with rights to the Good Start® brand [2]. - Allegations include significant underinvestment in the acquired infant formula business, necessitating higher-than-expected capital expenditures for remediation [3]. Financial Disclosures and Stock Impact - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation, alongside a 50% decline in earnings per share compared to the previous year, leading to a stock price drop of over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% stock price drop [5]. - On August 6, 2025, adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing a stock price decline of more than 11% [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which led to a stock price drop of over 25% [7].